Beta Synapset grande capsules E
Natural health product licensed in Canada
- Licence holder
- Bioflash inc
- NPN or DIN-HM
- 80108481
- Status
- Active licence
- Licence date
- 2 March 2021
- Revision date
- Not provided
- Form
- Capsule, enrobage gélatine
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Malate de magnésium | 37.5 mg | Not calculated |
| Huile de poisson Source : Poisson d'huile de poisson - en entier Potency : 54 mg Acide docosahexaénoïque | 450 mg | Not calculated |
| Huile de poisson Source : Poisson d'huile de poisson - en entier Potency : 81 mg Acide éicosapentaénoïque | Not specified | Not calculated |
Non-medicinal ingredients
Phosphate dicalcique, Sorbate de potassium, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 2 Tous les jours |
| Adolescentes | minimum: 14 years ; maximum: 18 years | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Aide à prévenir les déficiences alimentaires observées chez les individus souffrant de TDA/TDAH: magnésium, zinc, vitamine B6 et acides gras (AEP, ADH). Aide à contribuer à la santé cognitive et/ou aux fonctions cérébrales. Des études cliniques ont montré que chez les enfantssouffrant de TDAH certains acides gras sont déficients et qu'un apport de certains Omega-3 dont AEP exercait une influence bénéfique sur leur comportement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Non recommandée aux personnes souffrant d'allergies aux poissons.
Source
Official Health Canada record, licence 80108481
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.